Aquatic Capital Management’s Genmab GMAB Stock Holding History

Aquatic Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	+10,849	New	+$288K	0.01%	930
2026 Q1	–	Sell	-23,781	Closed	-$732K	–	1552
2025 Q4	$732K	Buy	23,781 +13,926	+141%	+$434K	0.02%	627
2025 Q3	$302K	Buy	+9,855	New	+$240K	0.01%	999
2025 Q1	–	Sell	-5,459	Closed	-$114K	–	1389
2024 Q4	$114K	Buy	+5,459	New	+$120K	﹤0.01%	1045
2024 Q3	–	Sell	-27,600	Closed	-$694K	–	1294
2024 Q2	$694K	Buy	+27,600	New	+$783K	0.03%	471
2024 Q1	–	Sell	-23,700	Closed	-$755K	–	1377
2023 Q4	$755K	Buy	23,700 +11,800	+99%	+$370K	0.02%	535
2023 Q3	$420K	Buy	11,900 +3,100	+35%	+$118K	0.02%	522
2023 Q2	$334K	Buy	+8,800	New	+$351K	0.02%	537
2022 Q2	–	Sell	-100	Closed	-$4K	–	1337
2022 Q1	$4K	Hold	100	–	–	0.01%	866
2021 Q4	$4K	Buy	+100	New	+$4.17K	0.01%	969

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aquatic Capital Management's GMAB Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Genmab (GMAB) in Q2 2026: 10,849 shares worth $298K. The stake represents 0.01% of the portfolio and ranks #930 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in GMAB as recently as Q4 2025.

Aquatic Capital Management first reported a position in GMAB in Q4 2021 and has held it in 10 quarters since. The position peaked at $755K in Q4 2023. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Aquatic Capital Management held 10,849 shares of Genmab worth $298K as of Q2 2026.
Genmab was a new Aquatic Capital Management position in Q2 2026.
Genmab made up 0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #930 holding.
Aquatic Capital Management first reported a position in Genmab in Q4 2021 and has held it in 10 quarters since.
Aquatic Capital Management's Genmab position peaked at $755K in Q4 2023.
291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.